Completed EUCTR 2017-001447-12
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In United States Schizophrenia Drug i A study involving a medication or substance. From 13 Years to 17 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04136873
This summary needs review. Please check the official study record and contact the research team for details.
In United States Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Cerevel Therapeutics, LLC
Condition Schizophrenia Completed NCT02611752
This summary needs review. Please check the official study record and contact the research team for details.
In United States Addiction Drug From 18 Years to 55 Years
Countries United States
Sponsor Braeburn Pharmaceuticals
Condition Addiction Completed NCT01870999
This study is completed in the United States. It focuses on schizophrenia.
In United States Schizophrenia Drug From 18 Years to 64 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT04567524
This study is completed in the United States. It focuses on Schizophrenia.
In United States Schizophrenia Drug From 18 Years to 50 Years
Countries United States
Sponsor Lyndra Inc.
Condition Schizophrenia Completed NCT01532999
This study is completed in the United States. It is testing multisite Randomized Controlled Trial of Mindfulness Meditation Therapy for PTSD.
In United States PTSD Behavioral Over 18 Years
Countries United States
Sponsor US Department of Veterans Affairs
Condition PTSD Completed NCT04473755
This summary needs review. Please check the official study record and contact the research team for details.
In United States ADHD Observational i A study where researchers collect information without assigning a treatment. From 16 Years to 30 Years
Countries United States
Sponsor Florida International University
Condition ADHD Completed NCT07399457
This summary needs review. Please check the official study record and contact the research team for details.
In United States Anxiety, Depression Behavioral Over 18 Years
Countries United States
Sponsor Kansas State University
Condition Anxiety, Depression Completed NCT03260257
This summary needs review. Please check the official study record and contact the research team for details.
In United States Schizophrenia Other From 18 Years to 65 Years
Countries United States
Sponsor University of California, San Diego
Condition Schizophrenia Terminated NCT04201106
This study was terminated in the United States. It is testing Open-label Placebo for Depression.
In United States Depression Behavioral From 13 Years to 18 Years
Countries United States
Sponsor University of California, San Francisco
Condition Depression Completed NCT03505905
This summary needs review. Please check the official study record and contact the research team for details.
In United States Depression Drug From 40 Years to 67 Years
Countries United States
Sponsor University of Texas Southwestern Medical Center
Condition Depression Completed NCT01952041
This summary needs review. Please check the official study record and contact the research team for details.
In United States Schizophrenia Behavioral Over 18 Years
Countries United States
Sponsor Dartmouth-Hitchcock Medical Center
Condition Schizophrenia 
